Reuters logo
BRIEF-Interpace Diagnostics announces increased reimbursement for ThyGenX
October 11, 2017 / 1:44 PM / in 11 days

BRIEF-Interpace Diagnostics announces increased reimbursement for ThyGenX

Oct 11 (Reuters) - Interpace Diagnostics Group Inc

* Interpace Diagnostics Group - ‍reimbursement for ThyGenx molecular test for indeterminate thyroid nodules will increase by 40% starting Jan 1, 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below